No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs544851144 |
chr1:93003664-93003665 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs560298299 |
chr1:93003666-93003667 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs192157928 |
chr1:93003692-93003693 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs34049819 |
chr1:93003712-93003713 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs35199577 |
chr1:93003721-93003722 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs542950542 |
chr1:93003733-93003734 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs139209754 |
chr1:93003805-93003806 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs531360754 |
chr1:93003870-93003871 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs565443228 |
chr1:93003938-93003939 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs149950737 |
chr1:93003948-93003949 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs2151576 |
chr1:93003949-93003950 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs370208654 |
chr1:93003996-93003997 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs549885953 |
chr1:93004032-93004033 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs565569859 |
chr1:93004042-93004043 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs184937156 |
chr1:93004068-93004069 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs144681304 |
chr1:93004106-93004107 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs187907518 |
chr1:93004177-93004178 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs572594674 |
chr1:93004183-93004184 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs553863815 |
chr1:93004195-93004196 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs2151577 |
chr1:93004219-93004220 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
21 |
rs555685055 |
chr1:93004276-93004277 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs192266930 |
chr1:93004321-93004322 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs567523868 |
chr1:93004353-93004354 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs184513236 |
chr1:93004354-93004355 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs536659400 |
chr1:93004362-93004363 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs189618506 |
chr1:93004384-93004385 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs564329117 |
chr1:93004385-93004386 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs578002053 |
chr1:93004400-93004401 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs545493523 |
chr1:93004491-93004492 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs7513775 |
chr1:93004497-93004498 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
31 |
rs572252879 |
chr1:93004498-93004499 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs139829351 |
chr1:93004504-93004505 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs181947226 |
chr1:93004525-93004526 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs74101190 |
chr1:93004537-93004538 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
35 |
rs184734626 |
chr1:93004546-93004547 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs564877151 |
chr1:93004551-93004552 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs532066618 |
chr1:93004571-93004572 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs547507863 |
chr1:93004597-93004598 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs189540897 |
chr1:93004621-93004622 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs180741459 |
chr1:93004669-93004670 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs562970149 |
chr1:93004775-93004776 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs145493414 |
chr1:93004788-93004789 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs373593757 |
chr1:93004793-93004794 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs72964704 |
chr1:93004817-93004818 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
45 |
rs538154698 |
chr1:93004822-93004823 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs556099051 |
chr1:93004826-93004827 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs147692984 |
chr1:93004837-93004838 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs376623429 |
chr1:93004972-93004973 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs6658734 |
chr1:93004992-93004993 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs10735778 |
chr1:93005006-93005007 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|